VERAXA Biotech Secures 275M Financing Plans Public Listing via SPAC Merger SBH Q1 2026 Earnings EPS Surpasses Estimates Despite Flat Revenue Environment Plus500 Reports 11 Quarterly Revenue Growth Reaffirms FullYear Expectations